Discovery of Novel Biomarkers of Therapeutic Responses in Han Chinese Pemetrexed-Based Treated Advanced NSCLC Patients

Pemetrexed, one of the most commonly used drugs in advanced non–small cell lung cancer (NSCLC) therapies, often leads to various therapeutic responses in patients. These therapeutic responses to pemetrexed, including adverse drug reactions (ADRs) and its intended therapeutic effects, have been demon...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Zhang, Xiaoqing, Zhang, Di, Huang, Lihua, Li, Guorong, Chen, Luan, Ma, Jingsong, Li, Mo, Wei, Muyun, Zhou, Wei, Zhou, Chenxi, Zhu, Jinhang, Wang, Zhanhui, Qin, Shengying
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6716463/
https://ncbi.nlm.nih.gov/pubmed/31507426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00944
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados